scispace - formally typeset
D

Douglas J. Creedon

Researcher at Mayo Clinic

Publications -  36
Citations -  1630

Douglas J. Creedon is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Endometrial ablation & Population. The author has an hindex of 19, co-authored 36 publications receiving 1353 citations. Previous affiliations of Douglas J. Creedon include North Memorial Medical Center.

Papers
More filters
Journal ArticleDOI

Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

TL;DR: In this article, a review summarizes the similarities between growth and immune privilege in cancer and pregnancy and identifies areas for further investigation, and the knowledge gained from analyzing similarities and differences between the physiologic state of pregnancy and the pathology of cancer could lead to identification of new potential targets for cancer therapeutic agents.
Journal ArticleDOI

Potential contribution of the uterine microbiome in the development of endometrial cancer

TL;DR: The microbiome sequencing revealed that the microbiomes of all organs (vagina, cervix, Fallopian tubes, and ovaries) are significantly correlated and that there is a structural microbiome shift in the cancer and hyperplasia cases, distinguishable from the benign cases.
Journal ArticleDOI

Pregnancy's stronghold on the vaginal microbiome

TL;DR: Normal pregnancy is characterized by a microbiome that has low diversity and high stability, and comparative analyses showed that the vaginal microbiome during pregnancy is characterize by a marked dominance of Lactobacillus species in both Caucasian and African-American subjects.
Journal ArticleDOI

Prediction of treatment outcomes after global endometrial ablation.

TL;DR: Population-derived rates and predictors of treatment outcomes after global endometrial ablation may help physicians offer optimal preprocedural patient counseling.
Journal ArticleDOI

A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease.

TL;DR: A multi-omic, systems-biology approach including both deep 16S rRNA gene-based sequencing and metabolomics of lavage samples from 36 women revealed two distinct symptomatic BV types with similar characteristics that indicated disruption of epithelial integrity, but each type was correlated to the presence of different microbial taxa and metabolites.